Viewing Study NCT06173505

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:29 AM
Ignite Modification Date: 2025-12-26 @ 2:11 AM
Study NCT ID: NCT06173505
Status: RECRUITING
Last Update Posted: 2024-12-04
First Post: 2023-11-13
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: Study of Vudalimab or Pembrolizumab in Combination With Chemotherapy as First-line Treatment in Patients With Advanced NSCLC
Sponsor: Xencor, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Nonsquamous Non-small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-small cell lung cancer View
None Nonsquamous View
None XmAb20717 View
None vudalimab View
None anti-PD-1 x anti-CTLA-4 View
None checkpoint inhibitor View
None chemotherapy View